GPC3 targeting CAR-T cell therapy (Essen Biotech)

GPC3靶向CAR-T（埃森生物）

Report date: 2026/05/18 20:02:07

Base Information

Drug NameGPC3 targeting CAR-T cell therapy (Essen Biotech)

Drug Alias NameGPC3 CAR-T cells(Essen)

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionGlypican-3 modulators

TargetsGlypican-3

Therapy Area/IndicationsOvarian NeoplasmsCarcinoma, Ovarian Epithelial

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesEssen Biotech

China Registration ClassN/A

Develop Information

Active CompaniesEssen Biotech

Inactive CompaniesN/A

Active IndicationsOvarian NeoplasmsCarcinoma, Ovarian Epithelial

Inactive IndicationsN/A

Other Information

ATC CodeN/A